1. Home
  2. EVOK vs SGLY Comparison

EVOK vs SGLY Comparison

Compare EVOK & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • SGLY
  • Stock Information
  • Founded
  • EVOK 2007
  • SGLY 2001
  • Country
  • EVOK United States
  • SGLY United States
  • Employees
  • EVOK N/A
  • SGLY N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • EVOK Health Care
  • SGLY
  • Exchange
  • EVOK Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • EVOK 4.2M
  • SGLY 3.9M
  • IPO Year
  • EVOK 2013
  • SGLY 2008
  • Fundamental
  • Price
  • EVOK $2.70
  • SGLY $1.11
  • Analyst Decision
  • EVOK
  • SGLY
  • Analyst Count
  • EVOK 0
  • SGLY 0
  • Target Price
  • EVOK N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • EVOK 19.3K
  • SGLY 53.3K
  • Earning Date
  • EVOK 08-12-2025
  • SGLY 08-26-2025
  • Dividend Yield
  • EVOK N/A
  • SGLY N/A
  • EPS Growth
  • EVOK N/A
  • SGLY N/A
  • EPS
  • EVOK N/A
  • SGLY N/A
  • Revenue
  • EVOK $11,594,083.00
  • SGLY $2,172,036.00
  • Revenue This Year
  • EVOK $57.82
  • SGLY N/A
  • Revenue Next Year
  • EVOK $59.12
  • SGLY N/A
  • P/E Ratio
  • EVOK N/A
  • SGLY N/A
  • Revenue Growth
  • EVOK 89.89
  • SGLY N/A
  • 52 Week Low
  • EVOK $1.94
  • SGLY $0.54
  • 52 Week High
  • EVOK $12.32
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 43.42
  • SGLY 59.35
  • Support Level
  • EVOK $2.50
  • SGLY $0.93
  • Resistance Level
  • EVOK $2.84
  • SGLY $1.10
  • Average True Range (ATR)
  • EVOK 0.20
  • SGLY 0.08
  • MACD
  • EVOK -0.01
  • SGLY -0.01
  • Stochastic Oscillator
  • EVOK 47.45
  • SGLY 78.26

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: